Beyond the brain: widespread pathology in Huntington's disease

被引:258
|
作者
van der Burg, Jorien M. M. [1 ]
Bjorkqvist, Maria [1 ]
Brundin, Patrik [1 ]
机构
[1] Lund Univ, Neuronal Survival Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden
来源
LANCET NEUROLOGY | 2009年 / 8卷 / 08期
基金
瑞典研究理事会;
关键词
TRANSGENIC MOUSE MODEL; CHOLESTEROL-BIOSYNTHESIS PATHWAY; PITUITARY-ADRENAL AXIS; PERIPHERAL-BLOOD CELLS; EXPANDED CAG REPEAT; R6/2; MOUSE; GENE-EXPRESSION; WEIGHT-LOSS; INCREASED APOPTOSIS; DIABETES-MELLITUS;
D O I
10.1016/S1474-4422(09)70178-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a polyglutamine stretch in the huntingtin protein. Today, more than 15 years after the genetic defect underlying HD was discovered, the pathogenesis is still not well understood and there is no adequate treatment. Research into this disorder has conventionally focused on neurological symptoms and brain pathology, particularly neurodegeneration in the basal ganglia and cerebral cortex. Mutant huntingtin is, however, ubiquitously expressed throughout the body. Indeed, contrary to earlier thinking, HD is associated with abnormalities in peripheral tissues. These abnormal changes are not all secondary to brain dysfunction, but most seem to be directly caused by expression of mutant huntingtin in peripheral tissues. In this article, we highlight this emerging field of research and how it might affect our understanding of the pathogenesis of this disease, the development of novel biomarkers of disease progression, and the identification of new potential treatments.
引用
收藏
页码:765 / 774
页数:10
相关论文
共 50 条
  • [11] Skeletal muscle pathology in Huntington's disease
    Zielonka, Daniel
    Piotrowska, Izabela
    Marcinkowski, Jerzy T.
    Mielcarek, Michal
    FRONTIERS IN PHYSIOLOGY, 2014, 5
  • [12] The early cellular pathology of Huntington’s disease
    Xiao-Jiang Li
    Molecular Neurobiology, 1999, 20 : 111 - 124
  • [13] The spectrum of tau pathology in Huntington's disease
    Baskota, Swikrity Upadhyay
    Lopez, Oscar
    Kofler, Julia
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2018, 77 (06): : 529 - 529
  • [14] Consistent and Widespread Degeneration of the Cerebellum in Huntington's Disease (HD)
    Rueb, Udo
    Vonsattel, Jean Paul G.
    Heinsen, Helmut
    Korf, Horst-Werner
    NEUROPATHOLOGY OF HUNTINGTON'S DISEASE: CLASSICAL FINDINGS, RECENT DEVELOPMENTS AND CORRELATION TO FUNCTIONAL NEUROANATOMY, 2015, 217 : 54 - 65
  • [15] Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target
    Schole, Melissa
    Patassini, Stefano
    Xu, Jingshu
    Cooper, Garth J. S.
    EBIOMEDICINE, 2023, 97
  • [16] Huntington's disease and brain development
    Humbert, Sandrine
    Barnat, Monia
    COMPTES RENDUS BIOLOGIES, 2022, 345 (02) : 77 - 90
  • [17] Brain stimulation in Huntington's disease
    Hartmann, Christian Johannes
    Groiss, Stefan Jun
    Vesper, Jan
    Schnitzler, Alfons
    Wojtecki, Lars
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (03) : 223 - 236
  • [18] Toward understanding the molecular pathology of Huntington's Disease
    Wellington, CL
    Brinkman, RR
    OKusky, JR
    Hayden, MR
    BRAIN PATHOLOGY, 1997, 7 (03) : 979 - 1002
  • [19] SUMO modification of Huntingtin and Huntington's disease pathology
    Steffan, JS
    Agrawal, N
    Pallos, J
    Rockabrand, E
    Trotman, LC
    Slepko, N
    Illes, K
    Lukacsovich, T
    Zhu, YZ
    Cattaneo, E
    Pandolfi, PP
    Thompson, LM
    Marsh, JL
    SCIENCE, 2004, 304 (5667) : 100 - 104
  • [20] Sirtuins as Modifiers of Huntington's Disease (HD) Pathology
    Neo, Sin Hui
    Tang, Bor Luen
    SIRTUINS IN HEALTH AND DISEASE, 2018, 154 : 105 - 145